Protein DoseSparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVACHIV vCP2438 and Adjuvanted Bivalent Subtype C gp120

Simple item page
dc.article.end-page415en
dc.article.start-page405en
dc.citation.doi10.1093/INFDIS/JIAD434en
dc.contributor.authorZ M Chirenjeen
dc.contributor.authorFatima Laheren
dc.contributor.authorO Dintween
dc.contributor.authorM Muyoyetaen
dc.contributor.authorA C deCampen
dc.contributor.authorE et alen
dc.date.accessioned2025-01-26T18:34:54Z
dc.date.available2025-01-26T18:34:54Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0022-1899en
dc.identifier.urihttps://hdl.handle.net/10539/43687
dc.journal.titleProtein DoseSparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVACHIV vCP2438 and Adjuvanted Bivalent Subtype C gp120en
dc.journal.volume230en
dc.publisherOXFORD UNIV PRESS INCen
dc.titleProtein DoseSparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVACHIV vCP2438 and Adjuvanted Bivalent Subtype C gp120en
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
1018.83 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)